Inflammasome-related markers at the ICU admission are not associated with outcome in the critically ill COVID-19 patients

Barbara Adamik, Magdalena Ambrożek-Latecka, Barbara Dragan, Aldona Jeznach, Jakub Śmiechowicz, Waldemar Goździk, Tomasz Skirecki
doi: https://doi.org/10.1101/2021.10.30.21265662

Article usage

Article usage: November 2021 to August 2025

AbstractFullPdf
Nov 202164811146
Dec 2021346668
Jan 20221671420
Feb 202247014
Mar 202267518
Apr 2022111315
May 202246215
Jun 202254115
Jul 20223405
Aug 20224638
Sep 202245211
Oct 202233214
Nov 20223499
Dec 2022281011
Jan 20231776
Feb 202332811
Mar 20231713
Apr 202327217
May 202317114
Jun 2023953
Jul 2023917
Aug 2023221210
Sep 20232049
Oct 20231001
Nov 20232296
Dec 20231033
Jan 20241225
Feb 20241513
Mar 20242446
Apr 20241217
May 20241753
Jun 20242268
Jul 20241206
Aug 20241336
Sep 202422111
Oct 20241454
Nov 20242629
Dec 20241507
Jan 202531613
Feb 20251419
Mar 202552156
Apr 2025341113
May 202530512
Jun 2025331317
Jul 2025221414
Aug 2025467
Back to top
Posted December 06, 2021.
Download PDF
Data/Code
Email
Inflammasome-related markers at the ICU admission are not associated with outcome in the critically ill COVID-19 patients
Barbara Adamik, Magdalena Ambrożek-Latecka, Barbara Dragan, Aldona Jeznach, Jakub Śmiechowicz, Waldemar Goździk, Tomasz Skirecki
medRxiv 2021.10.30.21265662; doi: https://doi.org/10.1101/2021.10.30.21265662
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area